Third-line chemotherapy in small-cell lung cancer: an international analysis.
Summers, Yvonne J
MetadataShow full item record
AbstractSmall-cell lung cancer is an aggressive disease for which the mainstay of treatment is chemotherapy. Despite good initial responses most patients will relapse. Some will receive second-line therapy with clinical benefit, but for third-line chemotherapy there is little evidence to guide treatment decisions and the benefits of treatment are unknown. This study investigated the treatment of SCLC in the third-line setting.
CitationThird-line chemotherapy in small-cell lung cancer: an international analysis. 2013: Clin Lung Cancer
JournalClinical Lung Cancer